Better stroke outcomes,
made possible.
The Unmet Need
Large Vessel Occlusion (LVO) strokes cause 95% of stroke-related deaths¹, yet EMS teams lack the tools to identify them in the field. As a result, most patients miss the narrow window for Endovascular Thrombectomy (EVT) treatment, leading to preventable disability and death.
1.Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review" in Frontiers in Neurology (2017)
About Endovate
At Endovate, our mission is to empower first responders with a fast, accurate, and non-invasive solution to detect LVO strokes at the point of care—ensuring patients get to the right hospital, the first time. By combining clinical insight, cutting-edge technology, and collaboration with frontline providers, we’re working to close the gap between stroke onset and treatment—because every minute matters.
Bhavya Dasari, MBA
CEO
Meet The Team
Mihai Truica, MD/PhD
CSO
Xueyang (Claire) Zha, MS Biotech
COO
Namrata Chintalapati, MD/MBA
CMO
Dhinal Thakker, MS Biotech
CPO
Contact Us
Interested in working together? Fill out a few details, and our team will be in touch shortly. We look forward to hearing from you!